Development and characterization of <scp>UV</scp>‐curable <scp>PCL</scp>/<scp>AESO</scp>/<scp>CNT</scp> nanocomposites for biomedical engineering

Abstract This study investigates the development and characterization of UV‐curable Poly(ε‐caprolactone) (PCL), Acrylated Epoxidized Soybean Oil (AESO), and Carbon Nanotubes (CNT) nanocomposites for biomedical engineering applications. The PCL/AESO blends were prepared in various ratios, and CNTs were incorporated at concentrations of 0.5, 1.0, and 1.5 wt% to enhance mechanical properties. The UV‐curable formulations aimed to leverage rapid curing times, precise control over material properties, and the ability to fabricate complex structures. Results indicated that the incorporation of CNTs improved the tensile strength, modulus, and toughness of the composites. The PCL/AESO/CNT nanocomposites exhibited a tensile strength increase of 25%, a modulus improvement of 30%, and a toughness enhancement of 20% compared to pure PCL. Thermal analysis showed an increase in crystallization temperature and thermal stability, with a crystallinity degree of 63.31% and a maximum degradation temperature of 407°C for the B/C 50/50/1.5 sample. Biocompatibility assessments using L929 fibroblast cells revealed that the composites supported cell viability and proliferation over 7 days with negligible cytotoxicity. Cell attachment studies indicated favorable morphology and adherence, suggesting a conducive environment for cell growth and differentiation. Hydrolytic biodegradation studies demonstrated adjustable degradation rates, making these composites suitable for various biomedical applications requiring controlled biodegradation.